Multiple mechanisms that prevent excessive brain inflammation

Authors

  • Myung-Soon Yang,

    1. Department of Pharmacology, Ajou University School of Medicine, Suwon, Kyunggi-do, Korea
    2. Brain Disease Research Center, Ajou University School of Medicine, Suwon, Kyunggi-do, Korea
    Search for more papers by this author
  • Kyoung-Jin Min,

    1. Department of Pharmacology, Ajou University School of Medicine, Suwon, Kyunggi-do, Korea
    2. Brain Disease Research Center, Ajou University School of Medicine, Suwon, Kyunggi-do, Korea
    3. Neuroscience Graduate Program, Ajou University School of Medicine, Suwon, Kyunggi-do, Korea
    Search for more papers by this author
  • Eunhye Joe

    Corresponding author
    1. Department of Pharmacology, Ajou University School of Medicine, Suwon, Kyunggi-do, Korea
    2. Brain Disease Research Center, Ajou University School of Medicine, Suwon, Kyunggi-do, Korea
    3. Neuroscience Graduate Program, Ajou University School of Medicine, Suwon, Kyunggi-do, Korea
    • san-5 Woncheon-dong Youngtong-gu Suwon, Kyunggi-do, Korea, 442-721
    Search for more papers by this author

Abstract

Inflammation of the injured brain has a double-edged effect. Inflammation protects the brain from infection, but it aggravates injury. Furthermore, brain inflammation is considered a risk factor for neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases. Emerging evidence supports the activation of negative regulatory mechanisms during this process to prevent prolonged and extensive inflammation. The inflammatory stimulators themselves or products of inflammatory cells may induce the expression of negative feedback regulators, such as suppressor of cytokine signaling (SOCS)-family proteins, antioxidant enzymes, and antiinflammatory cytokines. Furthermore, death of activated microglia (major inflammatory cells in the brain) may regulate brain inflammation. Astrocytes, the most abundant cells in the brain, may also act in preventing microglial overactivation. Therefore, we propose that the extent and duration of brain inflammation is tightly regulated through the cooperation of multiple mechanisms to maximize antipathogenic effects and minimize tissue damage. © 2007 Wiley-Liss, Inc.

Ancillary